Speaker(s):
Eric Wright, PharmD - Geisinger - has nothing to disclose.
Moderator(s):
Joseph Valdez, MD, Geisinger - has nothing to disclose.
Learning Objectives:
At the conclusion of this session, the participant should be able to:
- Describe the burden of Opioid Use Disorder in Primary Care
- Discuss methods to address unidentified or untreated Opioid Use Disorder in Primary Care.
- Generalize findings from the COMPUTE 2.0 study to select Geisinger stakeholder groups.
Disclosure of Relevant Financial Relationships with/without Commercial Interests:
The Planning Committee consisting of Margaret Jarvis, MD, Jessica Sevecke-Hanrahan, PhD, Jessie Goldhirsh, MD, Priscilla Riley, LPC, Imad Melhem, MD, and DeAnn Hansum, PA-C have no identified disclosures.
CE Committee Member/Content Reviewers have nothing to disclose: Kelly Ryan Shaw, PsyD, Roxanna Larsen, MS, LAT, ATC
Any/All relevant financial relationships have been mitigated.
Content Disclosure:
This presentation/content is HIPAA compliant.
Commercial Support for this Session
None
Session date:
10/16/2025 - 11:00am to 12:00pm EDT
Location:
Virtual
Danville, PA
17822
United States
See map: Google Maps
Add to calendar:
- 1.00 AMA PRA Category 1 Credit™
- 1.00 ANCC
- 1.00 Approved for APA Credit
- 1.00 ASWB
- 1.00 Participation Credit
- 1.00 NBCC

Facebook
X
LinkedIn
Forward